Avalo Therapeutics (AVTX) Other Working Capital Changes (2014 - 2026)
Avalo Therapeutics (AVTX) posted Other Working Capital Changes of -$88000.0 for Q4 2023, down 200.0% on a QoQ basis from $88000.0 in Q3 2023, and up 75.14% year-over-year from -$50245.2 in Q4 2022.
Avalo Therapeutics (AVTX) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Avalo Therapeutics' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$88000.0 for Q4 2023.
- Quarterly Other Working Capital Changes rose 75.14% year-over-year to -$88000.0 in Q4 2023, while the trailing twelve-month figure through Mar 2024 was -$110000.0 (down 200.0% YoY) and the FY2023 annual result came in at -$88000.0, down 200.0% from the prior year.
- Other Working Capital Changes was -$88000.0 for Q4 2023 at Avalo Therapeutics, down from $88000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.8 million in Q4 2025 and bottomed at -$2.5 million in Q1 2025.
- A 5-year average of $217764.7 and a median of $53000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 75.14% in 2023, while the deepest fall reached 80.09% in 2023.
- Avalo Therapeutics' Other Working Capital Changes stood at $21412.0 in 2019, then sank by 1753.28% to -$354000.0 in 2022, then jumped by 75.14% to -$88000.0 in 2023.
- Business Quant data shows AVTX's Other Working Capital Changes at -$88000.0 in Q4 2023, $88000.0 in Q3 2023, and -$110000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | 4.77 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 236,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | -2.49 Mn |
| Mar 31, 2025 | -2.49 Mn |
| Mar 31, 2025 | -2.49 Mn |
| Dec 31, 2024 | -399,000.00 |
| Dec 31, 2024 | -399,000.00 |
| Dec 31, 2024 | -399,000.00 |
| Sep 30, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.78 Mn |